Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
about
Overexpression of Krüppel-like factor 4 in the human colon cancer cell line RKO leads to reduced tumorigenecityCOX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerLipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancerMechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cellsEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesThe significance of markers in the diagnosis of endometrial cancerNon steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityCyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancerInhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expressionCryptorchidism-induced CFTR down-regulation results in disruption of testicular tight junctions through up-regulation of NF-κB/COX-2/PGE215-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancerProstaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells.Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.Indolyl-quinuclidinols inhibit ENOX activity and endothelial cell morphogenesis while enhancing radiation-mediated control of tumor vasculature.Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort studyCo-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Regulation of male fertility by CFTR and implications in male infertility.Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance.Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.Clinical significance of vasculogenic mimicry in human gliomasRegulated expression of PTPRJ by COX-2/PGE2 axis in endothelial cells.A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cellsProstaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsAnti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell lineFrequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas.Cyclooxygenase-2 knockdown using retinoic acid chalcone (RAC), a promising therapeutic strategy for colon cancerCyclooxygenase-2 expression and angiogenesis in colorectal cancer.PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsCOX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells.Mast cell regulation of the immune response.Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductaseDiscriminating different cancer cells using a zebrafish in vivo assay.Cyclooxygenase-2 in cancer and angiogenesis.
P2860
Q24649675-F3264E22-0CB3-4DC3-8F9B-D9C563E63996Q24651871-DDCDBE0F-BD4F-45FA-945A-7B1AE370E2A3Q24800010-31C60F1C-299E-4467-97E0-164B70BE8474Q24810540-057DBDC1-8E41-48BB-B742-AE95120265ECQ26862642-88FB213B-970E-4031-B480-E5D79AC1BF3FQ28067066-D06396F6-3708-4438-88BB-9F0AF865EAD0Q28166312-3ED2B8D6-8F91-426C-97C1-0B69FBCCD059Q28167125-CC0504B6-D5E5-4F07-8860-1927BE054A21Q28199319-24EE53BF-8088-404F-9295-E16955D1F0CEQ28578305-8806156D-0F05-4375-A605-FAC13ABDB2D4Q28592082-43FD57BC-24A3-458C-B676-DFF79FF328EDQ30430640-10B418A7-A9CE-4DE7-A1D0-FE5598243076Q30436782-468663E1-AED4-4899-A276-24DCFFF30413Q30744878-3A147789-903C-42A8-8316-FA3D87AC50D8Q33314445-39F9619A-9748-4A96-A3CA-03B2879A0510Q33552232-70B2A849-0972-4C18-BB32-1833BF871EEEQ33758985-DAC2DF5C-E770-46ED-AED6-288BEC4D2001Q33994275-61ECBE8E-963E-41E4-A222-BF9E539D7AE9Q34251088-7CC3172A-CA6E-4677-B336-7F6CB67DACD5Q34282487-BD4F40F8-FD71-4A8D-A79A-1E61DBCCB4B8Q34605197-B21B1347-79E8-4D70-BAB2-486398B55863Q34833647-CD2C10B8-A547-42F3-BB0F-1BDD99F1BC23Q35117974-0BA74166-07FD-4F77-93E1-C5FAE7582FBCQ35148963-2EE59722-6F78-415E-8000-2B4363233701Q35406814-917F648F-2E84-4FD8-BA16-0F2F26E51531Q35532404-CA45812E-9098-433A-B71C-3CCDDFBE3AB3Q35633657-DFE83125-F207-4120-8379-EF418F24F402Q35713568-DC7D492B-7A3B-4C61-B970-BBB68EE08161Q35728009-8EB7B0C5-B9DC-4040-80EF-C28AA0C14CE0Q35788803-B6FAF375-F39C-4AF0-A8A5-0FDE9A8A50ECQ35929848-F8E1F18C-1C07-4193-A305-0033D51D948FQ36179801-662F5116-90C2-42E2-A586-9BF4E3A57CFDQ36241115-BF3E45A5-A668-4D06-B6F0-9A63431C479FQ36500327-C2369B0D-3F6D-4303-9123-5A749E307CA7Q36694470-E48D10A0-CA59-4C7F-8B9B-30DF7CBB33D5Q36771532-4E87CA93-4D9E-4F2A-90AB-92C3830DDDD2Q36834357-7CCE3D04-FCB7-4514-AE5A-7F2E5F774EB6Q36984844-BF3A4073-58AA-4741-84F8-E5D567CEC771Q37148181-F0F7A2E5-01C6-45CE-89FF-5CD401E59899Q37174279-11A1C86A-DDD1-499E-A959-ED9309537BCC
P2860
Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Cyclooxygenase inhibitors reta ...... invasiveness and angiogenesis.
@en
type
label
Cyclooxygenase inhibitors reta ...... invasiveness and angiogenesis.
@en
prefLabel
Cyclooxygenase inhibitors reta ...... invasiveness and angiogenesis.
@en
P2093
P356
P1476
Cyclooxygenase inhibitors reta ...... invasiveness and angiogenesis.
@en
P2093
C Chakraborty
P304
P356
10.1002/IJC.1376
P577
2001-08-01T00:00:00Z